REDWOOD CITY, Calif.,
Dec. 22, 2016 /PRNewswire/
-- Nevro Corp. (NYSE: NVRO), a global medical device company
that is providing innovative evidence-based solutions for the
treatment of chronic pain, today announced that its management will
be presenting at the 35th Annual J.P. Morgan Healthcare
Conference on Monday, January 9, 2017
in San Francisco.
Nevro management is scheduled to present at 11:00 a.m. PT. The presentation will be
accessible via a live audio webcast, accessible in the "Investors"
section of the company's website at:
http://www.nevro.com/Investors.
Following the presentation, an archived copy will be available
on the Investor Events and Presentations webpage of the Company's
website.
About Nevro
Headquartered in Redwood City,
California, Nevro is a global medical device company focused
on providing innovative products that improve the quality of life
of patients suffering from debilitating chronic pain. Nevro has
developed and commercialized the Senza spinal cord stimulation
(SCS) system, an evidence-based neuromodulation platform for the
treatment of chronic pain. The Senza system is the only SCS system
that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro
and the Nevro logo are trademarks of Nevro.
Investor Relations Contact:
Nevro Investor
Relations
Katherine Bock
(650) 433-3247
ir@nevro.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nevro-to-present-at-the-35th-annual-jp-morgan-healthcare-conference-300383168.html
SOURCE Nevro Corp.